Exosome-Loaded GelMA Hydrogel as a Cell-Free Therapeutic Strategy for Hypertrophic Scar Inhibition
In summary, the Exos-GelMA composite hydrogel exhibits significant potential for the prevention and treatment of HS. This study supports the feasibility of Exos-GelMA as a cell-free therapeutic approach for the management of HS.
Authors
- Shudong Sun (ORCID: https://orcid.org/0000-0002-3903-8861)
- Xiugong Gao (ORCID: https://orcid.org/0000-0002-7755-8905)
- Yanxia Zhao (ORCID: https://orcid.org/0000-0003-3706-6233)
- Kun Wang (ORCID: https://orcid.org/0000-0002-6430-4789)
- Yuxiu Liu (ORCID: https://orcid.org/0000-0003-0387-307X)
- Hui Wang (ORCID: https://orcid.org/0009-0005-8063-9051)
Institutions
- Weifang Medical University (CN)
- Weifang People's Hospital (CN)
Publication Details
- Journal
- Clinical Cosmetic and Investigational Dermatology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/ccid.s520913
- Citations
- 3
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.01